VERROW PHARMACEUTICALS, INC.

City:

Lenexa, Kansas

Country:

United States

Published Applications:

Last publication date:

2014-12-25

Patent Grants:

Last grant date:

2013-11-05

Top Inventors for applications by VERROW PHARMACEUTICALS, INC.

These are the the leading inventors for applications assigned to VERROW PHARMACEUTICALS, INC.:

Vernon D. Rowe 6 Shawnee, KS United States
Gerold L. MOSHER 2 Kansas City, MO United States

Recent patent applications by VERROW PHARMACEUTICALS, INC.

VERROW PHARMACEUTICALS, INC. based in Lenexa, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-12-25

US20140377185A9

Human necessities

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

#2 | 2013-12-05

US20130323181A1

Human necessities

STABILIZED FORMULATIONS CONTAINING IODINATED CONTRAST AGENTS AND CYCLODEXTRINS

#3 | 2012-12-20 ✅ Patent 8,574,551 granted on 2013-11-05

US20120321564A1

Human necessities

Compositions useful for reducing nephrotoxicity and methods of use thereof

#4 | 2011-02-03

US20110028413A1

Human necessities

Methods of Reducing Methotrexate Nephrotoxicity

#5 | 2011-02-03

US20110027390A1

Human necessities

Methods for Reducing Cisplatin Nephrotoxicity

#6 | 2010-04-15 ✅ Patent 8,277,779 granted on 2012-10-02

US20100093664A1

Human necessities

Compositions useful for reducing nephrotoxicity and methods of use thereof

#7 | 2009-06-18 ✅ Patent 8,192,721 granted on 2012-06-05

US20090155181A1

Human necessities

Compositions useful for reducing toxicity associated with gadolinium-based contrast agents

#8 | 2007-11-22 ✅ Patent 7,658,913 granted on 2010-02-09

US20070270380A1

Human necessities

Compositions useful for reducing nephrotoxicity and methods of use thereof

AssigneeID:

47709 ⎘